Pro Dex Inc. (PDEX) intrinsic value & 10-year financials

Pro Dex Inc. (PDEX) has a Graham intrinsic value of $88.69 per share. At $58.26 on Oct 17, 2026, the stock trades 34% below that value. Over the last 10 fiscal years revenue grew 14.2% a year to $66.6M, with an average return on invested capital of 19.1%.

Graham intrinsic value
$88.69
Share price (Oct 17, 2026)
$58.26
Price vs Graham value
34% below
Market cap
$195.8M
Revenue (FY2025)
$66.6M
Revenue growth (10-yr CAGR)
14.2%
ROIC (10-yr avg)
19.1%
Free cash flow (FY2025)
—

PDEX 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $66.6M $9.0M $2.67 — 16.1% 17.0%
FY2024 $53.8M $2.1M $0.60 — 13.3% 13.7%
FY2023 $46.1M $7.1M $1.95 — 12.5% 10.6%
FY2022 $42.0M $3.9M $1.02 -$2.5M 12.2% 12.0%
FY2021 $38.0M $4.5M $1.13 -$3.8M 11.9% 15.1%
FY2020 $34.8M $6.1M $1.50 $4.4M 20.3% 37.5%
FY2019 $27.2M $4.1M $0.97 $1.9M 18.4% 30.1%
FY2018 $22.5M $1.6M $0.37 $2.2M 10.6% 13.7%
FY2017 $21.9M $5.1M $1.25 $2.6M 12.5% 33.8%
FY2016 $20.2M $822.0K $0.20 $155.0K 2.6% 7.7%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

PRO DEX INC is a consistent compounder, expanding top-line revenue at 14.2% annually over the past decade.

PRO DEX INC has earned high returns on invested capital, averaging 19.1% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Over the decade, PRO DEX INC shows that management has aggressively returned capital to shareholders by retiring 19.5% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, PRO DEX INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $88.69 per share.

PDEX stock: frequently asked questions

What is the intrinsic value of Pro Dex Inc. (PDEX) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, PDEX's intrinsic value is about $88.69 per share.

Is PDEX stock undervalued?

At $58.26 (close on Oct 17, 2026), PDEX trades 34% below its Graham value of $88.69. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Pro Dex Inc. grown?

Revenue went from $20.2M in fiscal 2016 to $66.6M in fiscal 2025, a compound annual growth rate of 14.2%. Net income was $9.0M in fiscal 2025.

What is PDEX's return on invested capital?

Average ROIC over the last 10 fiscal years was 19.1%, and average return on equity was 22.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this PDEX data come from?

From Pro Dex Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Apr 30, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks